S. Ourabah

Loss of intestinal ChREBP impairs absorption of dietary sugars and prevents glycemic excursion curves

B. Tavitian, M. le Gall, R. Dentin, 2021, bioRxiv.

Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth

R. Dentin, C. Postic, S. Guilmeau, 2016, Oncogene.

MondoA/ChREBP: The usual suspects of transcriptional glucose sensing; Implication in pathophysiology.

P. Richards, J. Montagne, A. Burnol, 2017, Metabolism: clinical and experimental.